Table 2. Demographics and clinical characteristics of HAM/TSP patients (Training Set).
| Total | Stable HAM/TSP | Deteriorating HAM/TSP | ||
| n = 30 | n = 14 | n = 11 | p-value* | |
| Demographics | ||||
| Age, y** | 58 [37–75] | 54.5 [39–75] | 62 [53–72] | 0.0183† |
| Female sex | 80.0% | 64.3% | 90.9% | 0.1696‡ |
| Clinical characteristics | ||||
| Age of onset, y** | 48 [20–70] | 33 [20–58] | 57 [40–70] | 0.0021† |
| Disease duration, y** | 12.5 [1–33] | 19 [7–33] | 9 [1–13] | 0.0021† |
| OMDS** | 6 [2–11] | 5 [2–9] | 8 [5–11] | 0.0065† |
In the Training set, deteriorating patients were significantly older, experienced disease onset later in life, had been living with the disease for shorter periods, and were more severely disabled (OMDS).
Stable HAM/TSP vs Deteriorating HAM/TSP.
Data are expressed as median [range].
By Mann-Whitney test.
By Fisher's exact test.
OMDS = Osame's Motor Disability Score.